| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 414 |
| 1 | METHOTREXATE | 366 |
| 2 | PREDNISONE | 343 |
| 3 | ADALIMUMAB | 324 |
| 4 | FUROSEMIDE | 291 |
| 5 | RITUXIMAB | 272 |
| 6 | ETANERCEPT | 268 |
| 7 | ACETAMINOPHEN | 264 |
| 8 | DEXAMETHASONE | 247 |
| 9 | DEXAMETHASONE 1.5 MG | 247 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARIFENACIN HYDROBROMIDE | 117 | 0.1351 |
| 1 | MINERAL OIL | 34 | 0.0229 |
| 2 | CICLESONIDE | 175 | 0.0127 |
| 3 | GOLD | 59 | 0.0102 |
| 4 | ANAKINRA | 109 | 0.0064 |
| 5 | DESOXIMETASONE | 122 | 0.0063 |
| 6 | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | 35 | 0.0059 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 42 | 0.0050 |
| 8 | ERGOCALCIFEROL | 126 | 0.0042 |
| 9 | CHLORTHALIDONE | 43 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 895 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 421 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 374 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 358 |
| 4 | Benzodiazepine [EPC] | 320 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 315 |
| 6 | Loop Diuretic [EPC] | 307 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 240 |
| 8 | Thalidomide Analog [EPC] | 220 |
| 9 | Alkylating Drug [EPC] | 205 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Interleukin-6 Antagonist [EPC] | 7 | 0.0108 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 43 | 0.0073 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 109 | 0.0064 |
| 4 | Provitamin D2 Compound [EPC] | 126 | 0.0042 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 6 | Nitrogen Binding Agent [EPC] | 7 | 0.0029 |
| 7 | Human Immunoglobulin G [EPC] | 58 | 0.0028 |
| 8 | Nitrofuran Antibacterial [EPC] | 47 | 0.0027 |
| 9 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |